Beta-Stim


Public lists: Medical Devices (6123)

Beta-Stim - Minimally invasive implantable neuro-stimulator to treat obesity and type II diabetic patients.

Beta-Stim - Minimally invasive implantable neuro-stimulator to treat obesity and type II diabetic patients.

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Beta-Stim $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Beta-Stim Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

LuMend

Redwood City, California, United States
AcquiredLuMend, Inc. is developing, manufacturing and marketing medical devices that meet clinical needs in interventional cardiology and radiology. The company's products are designed to cross chronic total occlusions (CTOs) and allow for subsequent treatment using catheter-based, minimally invasive procedures. Per the company, despite the high incidence of CTOs in patients with coronary and peripheral vascular disease, the catheter-based technology options available to treat these patients in a pred...Show allLogin to see details

Second Sight Medical Products

Sylmar, California, United States
IPO / Went publicSecond Sight Medical Products manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. The Argus II Retinal Prosthesis System ("Argus II") is an approved device intended to restore some functional vision for people suffering from blindness. Argus II is approved for use in the United States and the European Economic Area.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Duodenal eating sensor Jul 24, 2008 Oct 07, 2014 Patent
Gi and pancreatic device for treating obesity and diabetes Jul 13, 2006 Jan 10, 2012 Patent
Gastrointestinal device for treating obesity and diabetes Jun 13, 2008 Apr 12, 2011 Patent
Implantable pulse generator programming via electrodes Dec 28, 2007 Jan 04, 2011 Patent